BSG and cancer: One might therefore envisage to use scFv-N18E2/M6-displaying BV particles as CD147-targeted vectors in future protocols of cancer biotherapy, to transfer therapeutic genes (e.g. suicide genes or proapoptotic genes) to CD147-overexpressing malignant cells.